Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Details for Australian Patent Application No. 2006230291 (hide)

Owner Novartis AG

Inventors Billstein, Stephan

Agent Davies Collison Cave

Pub. Number AU-A-2006230291

PCT Pub. Number WO2006/105216

Priority 60/666,537 30.03.05 US

Filing date 28 March 2006

Wipo publication date 5 October 2006

International Classifications

A61K 31/522 (2006.01)

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/105216 Priority application(s): WO2006/105216

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230292-Spirocyclic thrombin receptor antagonists

2006230285-A system and method for localizing imaging devices